BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18006813)

  • 1. Microtubule disruption and tumor suppression by mitogen-activated protein kinase phosphatase 4.
    Liu Y; Lagowski J; Sundholm A; Sundberg A; Kulesz-Martin M
    Cancer Res; 2007 Nov; 67(22):10711-9. PubMed ID: 18006813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel function of MKP-5/DUSP10, a phosphatase of stress-activated kinases, on ERK-dependent gene expression, and upregulation of its gene expression in colon carcinomas.
    Nomura M; Shiiba K; Katagiri C; Kasugai I; Masuda K; Sato I; Sato M; Kakugawa Y; Nomura E; Hayashi K; Nakamura Y; Nagata T; Otsuka T; Katakura R; Yamashita Y; Sato M; Tanuma N; Shima H
    Oncol Rep; 2012 Sep; 28(3):931-6. PubMed ID: 22711061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonistic Interactions between Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and Retinoic Acid Receptor Signaling in Colorectal Cancer Cells.
    Imajo M; Kondoh K; Yamamoto T; Nakayama K; Nakajima-Koyama M; Nishida E
    Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28483913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
    Reffas S; Schlegel W
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.
    Yip-Schneider MT; Lin A; Marshall MS
    Biochem Biophys Res Commun; 2001 Feb; 280(4):992-7. PubMed ID: 11162624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
    Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual specificity phosphatases 10 and 16 are positive regulators of EGF-stimulated ERK activity: indirect regulation of ERK signals by JNK/p38 selective MAPK phosphatases.
    Finch AR; Caunt CJ; Perrett RM; Tsaneva-Atanasova K; McArdle CA
    Cell Signal; 2012 May; 24(5):1002-11. PubMed ID: 22245064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells.
    Waha A; Felsberg J; Hartmann W; von dem Knesebeck A; Mikeska T; Joos S; Wolter M; Koch A; Yan PS; Endl E; Wiestler OD; Reifenberger G; Pietsch T; Waha A
    Cancer Res; 2010 Feb; 70(4):1689-99. PubMed ID: 20124482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.
    Rojo F; González-Navarrete I; Bragado R; Dalmases A; Menéndez S; Cortes-Sempere M; Suárez C; Oliva C; Servitja S; Rodriguez-Fanjul V; Sánchez-Pérez I; Campas C; Corominas JM; Tusquets I; Bellosillo B; Serrano S; Perona R; Rovira A; Albanell J
    Clin Cancer Res; 2009 May; 15(10):3530-9. PubMed ID: 19417026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MKP-7, a JNK phosphatase, blocks ERK-dependent gene activation by anchoring phosphorylated ERK in the cytoplasm.
    Masuda K; Katagiri C; Nomura M; Sato M; Kakumoto K; Akagi T; Kikuchi K; Tanuma N; Shima H
    Biochem Biophys Res Commun; 2010 Mar; 393(2):201-6. PubMed ID: 20122898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-translational regulation of mitogen-activated protein kinase phosphatase-2 (MKP-2) by ERK.
    Peng DJ; Zhou JY; Wu GS
    Cell Cycle; 2010 Dec; 9(23):4650-5. PubMed ID: 21084841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
    Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MKP-2: out of the DUSP-bin and back into the limelight.
    Lawan A; Torrance E; Al-Harthi S; Shweash M; Alnasser S; Neamatallah T; Schroeder J; Plevin R
    Biochem Soc Trans; 2012 Feb; 40(1):235-9. PubMed ID: 22260697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
    Bazuine M; Carlotti F; Tafrechi RS; Hoeben RC; Maassen JA
    Mol Endocrinol; 2004 Jul; 18(7):1697-707. PubMed ID: 15184525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs).
    Kidger AM; Keyse SM
    Semin Cell Dev Biol; 2016 Feb; 50():125-32. PubMed ID: 26791049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment.
    Lu H; Tran L; Park Y; Chen I; Lan J; Xie Y; Semenza GL
    Cancer Res; 2018 Aug; 78(15):4191-4202. PubMed ID: 29880481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osmotic regulation of insulin-induced mitogen-activated protein kinase phosphatase (MKP-1) expression in H4IIE rat hepatoma cells.
    Lornejad-Schäfer MR; Schäfer C; Graf D; Häussinger D; Schliess F
    Biochem J; 2003 Apr; 371(Pt 2):609-19. PubMed ID: 12529177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
    Magi-Galluzzi C; Mishra R; Fiorentino M; Montironi R; Yao H; Capodieci P; Wishnow K; Kaplan I; Stork PJ; Loda M
    Lab Invest; 1997 Jan; 76(1):37-51. PubMed ID: 9010448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
    Shi YY; Small GW; Orlowski RZ
    Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases.
    Pan MR; Chang HC; Hung WC
    Cell Signal; 2008 Jun; 20(6):1134-41. PubMed ID: 18374541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.